| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc. (GH) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. GH is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.03M | $261.30M | -100,000 | |
| Other | 79.1K | $10.19M | - | |
| CFO | 47.5K | $6.12M | -2,000 | |
| Other | 46.7K | $6.02M | - | |
| Other | 36.0K | $4.63M | -10,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2020 | Meresman Stanley J75 | Director | Sale+OE | 5,000 | $94.22 | $471,100.00 | -55.2% | |
| Sep 8, 2020 | Clark Ian T66 | Director | Sale+OE | 9,146 | $89.25 | $816,246.74 | -32.6% | |
| Sep 2, 2020 | Talasaz Amirali | Chairman, President And COO | Sell | 75,000 | $94.15 | $7,060,961.24 | -0.6% | |
| Sep 1, 2020 | Bertocci Derek A | Chief Financial Officer | Sell | 30,100 | $93.94 | $2,827,453.58 | -45.4% | |
| Aug 24, 2020 | Bertocci Derek A | Chief Financial Officer | Sale+OE | 9,992 | $94.39 | $943,102.45 | -5.9% | |
| Aug 17, 2020 | Kaul Samir | Director | Sell | 10,000 | $87.58 | $875,848.28 | -2.6% | |
| Aug 17, 2020 | Bertocci Derek A | Chief Financial Officer | Sell | 25,000 | $87.76 | $2,194,005.47 | -9.5% | |
| Aug 10, 2020 | Meresman Stanley J75 | Director | Sale+OE | 5,000 | $87.00 | $435,000.00 | -55.2% | |
| Aug 4, 2020 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 75,000 | $85.85 | $6,438,644.98 | -0.5% | |
| Jul 10, 2020 | Meresman Stanley J75 | Director | Sale+OE | 6,000 | $86.66 | $519,960.00 | -59.6% |